News & Statements
T1International Hosts 3rd Annual #insulin4all Workshop
13 Sep 2021, 6:38 p.m. in #insulin4all USA, News & Statements by T1International
Join us for T1International’s annual #insulin4all Workshop: Advocate, Don’t Celebrate. This event is an opportunity for advocates from around the world to learn from each other, build community, and take action in the fight for #insulin4all. Read more
T1International Comment on Application to Add Long-acting Insulin Analogues to WHO EML
17 Jun 2021, 9:03 a.m. in News & Statements by T1International
The WHO justifying inaction by saying it will not be adequate fails to address the issue of manufacturer monopolies and price-gouging. To see a world health leader taking this stance is extremely disheartening. Not to mention, civil society groups, including T1International, have coordinated actions to address the root causes of the issue. If the application is rejected for a third time, the diabetes community will continue to feel that the voices of people with diabetes do not matter and that the WHO is not listening to those who live this reality every day. Read more
T1International Statement Endorsing H.R.3
2 Jun 2021, 9:59 a.m. in News & Statements
For years, T1International and our advocates have been calling on both state and federal legislators to take action to address exorbitant drug prices. American lives depend on real action. That’s why T1International USA endorses the Elijah E. Cummings Lower Drug Costs Now Act (H.R.3). Read more
T1International Launches 100 Years: From Gift to Greed Campaign
17 May 2021, 11:04 a.m. in News & Statements by T1International
On Monday, May 17th - 100 years after Banting, Best and Macleod begin their first experiment trying to extract insulin in Toronto - T1International and its advocates around the world launch their year-long campaign. 100 Years: From Gift to Greed will tell the story of insulin’s discovery and how it went from being a gift to the world to a profit machine for the pharmaceutical industry. The campaign will be led by a combination of social media education and a variety of actions. Read more
T1International and Partners Statement on Victory in Emergency Insulin Case
17 Mar 2021, 5:50 p.m. in News & Statements by T1International
We know this battle might not be over, but it’s clearer than ever that the protection the Alec Smith Act offers to patients who are being exploited by Eli Lilly, Novo Nordisk, and Sanofi must be a primary concern for the courts going forward. Read more
T1International Statement on Freeze of Executive Actions
28 Jan 2021, 9:50 a.m. in #insulin4all USA, News & Statements by T1International
On January 20, President Biden issued a freeze on all new regulations that former President Trump had not finished implementing so his administration would have a chance to evaluate them and decide whether they should go into effect. These freezes are standard practice for a new administration taking over for a president of the opposite party; President Trump implemented a similar freeze on his first day in office in 2017. Read more
T1International Year in Review: 2020
22 Jan 2021, 3:24 p.m. in #insulin4all USA, News & Statements by T1International
What a year we had as a community and as an organization in 2020. There were many global challenges, as always, and COVID-19 had huge impacts across the world. Below is a taste of what, thanks to our advocates and supporters, we achieved. Read more
T1International Statement on Appointments by President-elect Biden
9 Dec 2020, 5:05 p.m. in #insulin4all USA, News & Statements by T1International
On November 16, it was first reported that President-elect Biden will appoint Steve Ricchetti as one of his counselors in the White House. We are disappointed that the President-elect would choose a former lobbyist for Eli Lilly and Sanofi to serve in such a senior post in his administration. Read more
T1International, Minnesota #insulin4all, and Partners Submit Amicus Brief for Alec Smith Bill
6 Nov 2020, 8:22 p.m. in #insulin4all USA, News & Statements by T1International
There is an insulin rationing crisis in the United States, driven by the high price of this life-saving medication. Research indicates that one-quarter of people with diabetes have to ration their insulin because of the cost, and rationing puts patients at greater risk of health complications, including death. In Minnesota, advocates responded to the deaths of Alec Raeshawn Smith and Jesimya David Scherer-Radcliff by fighting to pass the Alec Smith Insulin Affordability Act, which was the first in the nation to establish a program for patients with diabetes to purchase the insulin they need at an affordable price. After years of work, this bill was signed into law by Governor Tim Walz on April 15, 2020. Read more
There Is No Insulin in Iran
27 Oct 2020, 6:11 p.m. in Global Stories, News & Statements by Mahsa
Shortages of insulin are not something new in Iran, but recently there is no insulin at all. We were shocked by responses from our politicians who said, "The shortage is just for pens and we have plenty of internal production of insulin. People can replace it." However, the types of insulin that are produced in Iran are NPH and R. Few consumers in Iran use NPH. About 70 percent of Iranian people with diabetes use insulin pens. Read more